IRIS
PISAPIA, PASQUALE
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
AS - Asia 4.909
EU - Europa 3.457
NA - Nord America 2.998
SA - Sud America 631
AF - Africa 95
OC - Oceania 8
Continente sconosciuto - Info sul continente non disponibili 2
Totale 12.100
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 2.863
SG - Singapore 2.718
RU - Federazione Russa 1.804
CN - Cina 1.000
IT - Italia 804
HK - Hong Kong 535
BR - Brasile 525
VN - Vietnam 269
DE - Germania 241
IN - India 136
GB - Regno Unito 97
NL - Olanda 94
FI - Finlandia 84
KR - Corea 73
CA - Canada 65
ES - Italia 64
FR - Francia 64
MX - Messico 49
AR - Argentina 43
UA - Ucraina 39
ZA - Sudafrica 31
IE - Irlanda 28
BD - Bangladesh 27
PL - Polonia 26
EC - Ecuador 24
AT - Austria 23
JP - Giappone 20
SE - Svezia 20
CI - Costa d'Avorio 19
IQ - Iraq 17
TR - Turchia 17
LT - Lituania 14
ID - Indonesia 13
PK - Pakistan 13
UZ - Uzbekistan 10
JO - Giordania 9
PE - Perù 9
VE - Venezuela 9
BE - Belgio 7
EG - Egitto 7
KE - Kenya 7
PY - Paraguay 7
RS - Serbia 6
SA - Arabia Saudita 6
AE - Emirati Arabi Uniti 5
AU - Australia 5
CH - Svizzera 5
HU - Ungheria 5
MA - Marocco 5
RO - Romania 5
AL - Albania 4
AZ - Azerbaigian 4
CL - Cile 4
DZ - Algeria 4
NP - Nepal 4
TN - Tunisia 4
BG - Bulgaria 3
BO - Bolivia 3
BS - Bahamas 3
CO - Colombia 3
CZ - Repubblica Ceca 3
GA - Gabon 3
GR - Grecia 3
HN - Honduras 3
IL - Israele 3
KH - Cambogia 3
KZ - Kazakistan 3
MY - Malesia 3
OM - Oman 3
PA - Panama 3
PH - Filippine 3
TZ - Tanzania 3
AD - Andorra 2
BN - Brunei Darussalam 2
CR - Costa Rica 2
GF - Guiana Francese 2
GT - Guatemala 2
IR - Iran 2
JM - Giamaica 2
KG - Kirghizistan 2
MD - Moldavia 2
NG - Nigeria 2
NI - Nicaragua 2
NZ - Nuova Zelanda 2
PT - Portogallo 2
TW - Taiwan 2
UY - Uruguay 2
AM - Armenia 1
BY - Bielorussia 1
CD - Congo 1
CV - Capo Verde 1
DM - Dominica 1
EE - Estonia 1
ET - Etiopia 1
EU - Europa 1
GD - Grenada 1
GE - Georgia 1
GH - Ghana 1
HR - Croazia 1
HT - Haiti 1
Totale 12.081
Salva come PNG Salva come JPEG
Città #
Singapore 1.349
Hong Kong 528
Moscow 448
Hefei 388
Chandler 380
Ashburn 274
Beijing 261
Naples 181
Santa Clara 139
Ho Chi Minh City 108
Los Angeles 107
Millbury 107
Munich 100
Lawrence 89
Des Moines 79
Seoul 72
Milan 70
Redondo Beach 70
Kochi 63
Napoli 62
São Paulo 54
Buffalo 53
Hanoi 48
Helsinki 47
Boston 45
New York 43
Amsterdam 42
Rome 42
Wilmington 42
Valencia 40
Dallas 37
The Dalles 33
Frankfurt am Main 29
Seattle 26
Orem 24
Mexico City 22
Nanjing 22
Falkenstein 21
Rio de Janeiro 21
Fairfield 20
Ottawa 20
Atlanta 19
Chicago 19
Johannesburg 19
Warsaw 19
Chennai 18
London 18
Tokyo 17
Turku 17
Brooklyn 16
Haiphong 16
Houston 16
Montreal 16
Nuremberg 16
Da Nang 15
Dublin 15
Stockholm 14
Brasília 12
Lappeenranta 12
Phoenix 12
Princeton 12
Belo Horizonte 11
Denver 11
Düsseldorf 11
Redwood City 11
San Francisco 11
Amman 9
Ankara 9
Hải Dương 9
Kronberg 9
Ninh Bình 9
Salerno 9
Council Bluffs 8
Curitiba 8
Roubaix 8
Salt Lake City 8
Turin 8
Vienna 8
Woodbridge 8
Biên Hòa 7
Buenos Aires 7
Falls Church 7
Guayaquil 7
Karachi 7
Porto Alegre 7
Portsmouth 7
Pune 7
Ribeirão Preto 7
Shanghai 7
Tashkent 7
Toronto 7
Viareggio 7
Baghdad 6
Bexley 6
Bologna 6
Florence 6
Grosseto 6
Guangzhou 6
Guarulhos 6
Lauterbourg 6
Totale 6.228
Salva come PNG Salva come JPEG
Nome #
Performance analysis of SiRe next-generation sequencing panel in diagnostic setting: focus on NSCLC routine samples 181
Cell free DNA analysis by SiRe® next generation sequencing panel in non small cell lung cancer patients: focus on basal setting. 156
The Metallophosphoesterase-Domain-Containing Protein 2 (MPPED2) Gene Acts as Tumor Suppressor in Breast Cancer 148
Liquid biopsy as indication of tumour progression in lung cancer: A potential intervention in tertiary prevention 131
Next generation sequencing techniques in liquid biopsy: focus on non-small cell lung cancer patients 130
A Roadmap for a Comprehensive Diagnostic Approach to Fine Needle Cytology of Lymph Node Metastases 127
Evaluation of the Molecular Landscape in PD-L1 Positive Metastatic NSCLC: Data from Campania, Italy 126
PD-L1 expression in cell-blocks of non-small cell lung cancer: The impact of prolonged fixation 125
Genomic profiling of tissue and blood predicts survival outcomes in patients with resected pleural mesothelioma 124
Technical Validation of a Fully Integrated NGS Platform in the Real-World Practice of Italian Referral Institutions 119
Predictive molecular pathology in metastatic thyroid cancer: the role of RET fusions 117
RNA-based next generation sequencing in non-small-cell lung cancer in a routine setting: an experience from an Italian referral center 116
A MiR181/Sirtuin1 regulatory circuit modulates drug response in biliary cancers 116
Comparison of two next-generation sequencing-based approaches for liquid biopsy analysis in patients with non-small cell lung cancer: a multicentre study 115
Liquid biopsy for BRAF mutations testing in non-small cell lung cancer: A retrospective study 114
ALK and ROS1 testing on lung cancer cytologic samples: Perspectives 113
Impact of Pre-Analytical Factors on MSI Test Accuracy in Mucinous Colorectal Adenocarcinoma: A Multi-Assay Concordance Study 113
Moving towards a local testing solution for undetermined thyroid fine-needle aspirates: validation of a novel custom DNA-based NGS panel 110
Non-Small Cell Lung Cancer Testing on Reference Specimens: An Italian Multicenter Experience 109
Multiplex digital colour-coded barcode technology on RNA extracted from routine cytological samples of patients with non-small cell lung cancer: pilot study 108
Evaluation of BRAF, RAS, RET/PTC, and PAX8/PPARg alterations in different Bethesda diagnostic categories: A multicentric prospective study on the validity of the 7-gene panel test in 1172 thyroid FNAs deriving from different hospitals in South Italy 108
Rapid On-site Molecular Evaluation in thyroid cytopathology: A same-day cytological and molecular diagnosis 108
Development of a gene panel for next-generation sequencing of clinically relevant mutations in cell-free DNA from cancer patients 107
The continuing role of breast fine-needle aspiration biopsy after the introduction of the IAC Yokohama System For Reporting Breast Fine Needle Aspiration Biopsy Cytopathology 106
The role of liquid biopsy in epithelial ovarian cancer: state of the art 103
Evaluation of a fully closed real time PCR platform for the detection of SARS-CoV-2 in nasopharyngeal swabs: a pilot study 103
Circulating tumor DNA in cancer: Predictive molecular pathology meets mathematics 103
Liquid Biopsy in Prostate Cancer Management{\textemdash}Current Challenges and Future Perspectives 102
The biomarkers ATLAS: An audit on 1100 non-small cell lung cancer from an Italian knowledge-based database 101
Recent advances in the use of liquid biopsy for the diagnosis and treatment of lung cancer 101
RNA-Based Assay for Next-Generation Sequencing of Clinically Relevant Gene Fusions in Non-Small Cell Lung Cancer 101
EGFR mutation detection on lung cancer cytological specimens by the novel fully automated PCR-based Idylla EGFR Mutation Assay 100
Cytology meets next generation sequencing and liquid biopsy: A case of lung adenocarcinoma presenting as metastasis to the phalanx 100
Brca1/2 ngs somatic testing in clinical practice: a short report 100
PIK3CA testing in hormone receptor-positive/HER2-negative metastatic breast cancer: real-world data from Italian molecular pathology laboratories 99
KRAS mutations testing in non-small cell lung cancer: The role of Liquid biopsy in the basal setting 99
Next Generation Sequencing for liquid biopsy based testing in Non-Small Cell Lung Cancer in 2021 99
The evolving role of liquid biopsy in lung cancer 98
How Molecular and Ancillary Tests Can Help in Challenging Cytopathology Cases: Insights from the International Molecular Cytopathology Meeting 98
Ciliated foregut cyst of the pancreas: A benign lesion with elevated CEA levels 98
PD-L1 expression on routine samples of non-small cell lung cancer: Results and critical issues from a 1-year experience of a centralised laboratory 98
Next generation sequencing in cytology 98
Multiple predictive biomarker testing in melanoma: another challenge for the optimal approach on cytological samples 97
Harmonization of Next-Generation Sequencing Procedure in Italian Laboratories: A Multi-Institutional Evaluation of the SiRe® Panel 97
A narrative review of lung cancer cytology in the times of coronavirus: What physicians should know 97
Methods for actionable gene fusion detection in lung cancer: now and in the future 97
Role of Cytomorphology in the Era of Liquid Biopsy 96
Is the Idylla EGFR Mutation Assay feasible on archival stained cytological smears? A pilot study 96
Evaluation of Micro Satellite Instability and Mismatch Repair Status in Different Solid Tumors: A Multicenter Analysis in a Real World Setting 96
BRAF mutations in lung cancer 95
Mismatch repair proteins and microsatellite instability in solid pseudopapillary neoplasm of the pancreas 95
Unusual Clinical Experience in BRAF Exon 15 p.K601E-Mutated Lung Cancer: A Case Report and Brief Review of the Literature 94
There is still a role for cytology in the 'liquid biopsy' era. A lesson from a TKI-treated patient showing adenocarcinoma to squamous cell carcinoma transition during disease progression 94
Osimertinib 94
Liquid Biopsy Analysis in Clinical Practice: Focus on Lung Cancer 94
Predictive molecular pathology in the time of COVID-19 93
KRAS, NRAS and BRAF mutations detected by next generation sequencing, and differential clinical outcome in metastatic colorectal cancer (MCRC) patients treated with first line FIr-B/FOx adding bevacizumab (BEV) to triplet chemotherapy 92
Comparison between two different next generation sequencing platforms for clinical relevant gene mutation test in solid tumours 92
Dealing with NSCLC EGFR mutation testing and treatment: A comprehensive review with an Italian real-world perspective 92
Interventional cytopathologist can successfully combine ultrasonographical and microscopic skills to narrow the differential diagnosis in fine‐needle aspiration of neck paraganglioma 91
The evolving role of interventional cytopathology from thyroid FNA to NGS: Lessons learned at Federico II University of Naples 91
EGFR mutation detection on routine cytological smears of non-small cell lung cancer by digital PCR: A validation study 91
KRAS detection on archival cytological smears by the novel fully automated polymerase chain reaction-based Idylla mutation test 91
TargetPlex FFPE-Direct DNA Library Preparation Kit for SiRe NGS panel: an international performance evaluation study 91
Multi-gene custom panels for the characterisation of metastatic colorectal carcinoma in clinical practice: express the role of PIK3CA mutations 91
A narrative review of predictive immuno-histo/cyto chemistry in lung cancer: focus on gene fusions and PD-L1 expression 90
Next Generation Sequencing in Cytopathology: Focus on Non-Small Cell Lung Cancer 90
An Italian Multicenter Perspective Harmonization Trial for the Assessment of MET Exon 14 Skipping Mutations in Standard Reference Samples 89
Interobserver variability in cytopathology: How much do we agree? 88
Tumor mutational burden on cytological samples: A pilot study 88
BRAF: A Two-Faced Janus 88
Microsatellite instability evaluation of patients with solid tumour: routine practice insight from a large series of Italian referral centre 88
Consistency and reproducibility of next-generation sequencing in cytopathology: A second worldwide ring trial study on improved cytological molecular reference specimens 87
Concomitant Rare KRAS and BRAF Mutations in Lung Adenocarcinoma: A Case Report 87
A challenging case of enteric-type lung adenocarcinoma metastatic to the thyroid harboring RET-fusion diagnosed on fine-needle aspiration 86
Less frequently mutated genes in colorectal cancer: Evidences from next-generation sequencing of 653 routine cases 86
How to prepare cytological samples for molecular testing 86
Invited review—next-generation sequencing: a modern tool in cytopathology 85
Fine-Needle Aspiration Is Suitable for Breast Cancer BRCA Molecular Assessment: A Case Report 85
Liquid Biopsy and Lung Cancer 84
Next generation sequencing identifies novel potential actionable mutations for grade I meningioma treatment 83
Profile of the Roche cobas® EGFR mutation test v2 for non-small cell lung cancer 82
Cytopathology practice during the COVID-19 postlockdown: An Italian experience 81
COVID-19 pandemic impact on cytopathology practice in the post-lockdown period: An international, multicenter study 81
Evaluating local thyroid cytopathology practices by molecular quality metrics: A multi‐institutional study on 4651 FNAs with a focus on the role of the interventional cytopathologist 81
EGFR exon 19 deletion switch and development of p.L792Q mutation as a new resistance mechanism to osimertinib: A case report and literature review 80
BRAF as a positive predictive biomarker: Focus on lung cancer and melanoma patients 79
Molecular testing in salivary gland cytopathology: A practical overview in conjunction with the Milan system 77
Tissue Microarray from Cell Block Material (cbTMA)—An Additional Shot for Cytology in the Predictive Pathology Era: The PD-L1 Experience 77
A simplified genomic profiling approach predicts outcome in metastatic colorectal cancer 76
Critical aspects of MSI testing in endometrial cancer: a comparison study 75
Bird's eye view of modern cytopathology: Report from the seventh international Molecular Cytopathology Meeting in Naples, Italy, 2018 75
RNA-Based Next-Generation Sequencing in Non-Small Cell Lung Cancer patients: data from Campania, Italy 74
Juggling the COVID-19 pandemic: A cytopathology point of view 73
Biologics for novel driver altered non-small cell lung cancer: potential and pitfalls 70
Cytopathologists can reliably perform ultrasound-guided thyroid fine needle aspiration: a 1-year audit on 3715 consecutive cases 70
Global impact of the COVID-19 pandemic on cytopathology practice: Results from an international survey of laboratories in 23 countries 68
Cytopathology Practice in the COVID-19 Era: Focus on Sample Workload 67
Prevalence of KRAS, NRAS and BRAF mutations detected by massive parallel sequencing and differential clinical outcome in metastatic colorectal cancer (MCRC) patients (pts) treated with first line FIr-B/FOx adding bevacizumab (BEV) to triplet chemotherapy 66
Consistency and reproducibility of next-generation sequencing and other multigene mutational assays: A worldwide ring trial study on quantitative cytological molecular reference specimens 66
Totale 9.693
Salva come PNG Salva come JPEG
Categoria #
all - tutte 41.859
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 41.859
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021249 0 0 0 0 0 69 20 49 31 34 25 21
2021/2022623 42 15 21 9 11 12 16 69 22 51 132 223
2022/2023923 116 58 40 67 125 115 4 107 172 44 58 17
2023/2024713 42 123 50 29 29 37 25 98 22 38 127 93
2024/20254.400 204 235 21 22 99 191 465 275 306 621 1.563 398
2025/20265.109 861 795 911 779 1.419 344 0 0 0 0 0 0
Totale 12.353